Psyence Group Inc. announced the appointments of Dr. Amza Ali and Mr. Kevin Coyne as executives of the Company. Dr. Ali, an existing member of the board of Psyence, will move into a more material executive leadership position with the Company as Global Medical Director and BPH is supporting Mr. Coyne’s appointment as Global Commercial Director of Psyence. Dr. Ali is a graduate of the University of the West Indies subsequently specializing in Internal Medicine. He then trained in Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square, London and is specialty certified in Neurology by the Federation of Royal Colleges of Physicians of the United Kingdom and the Association of British Neurologists. He was appointed a lifetime Global Ambassador for Epilepsy in 2019. Mr. Coyne is the co-founder of Coyne Healthcare, a leading integrative medicine business based out of Cape Town, South Africa. Mr. Coyne has collaborated with world experts, developing nature-based healthcare products that have been scientifically validated and produced to the highest global standards. Mr. Coyne is also BPH’s lead psilocybin Product Development Advisor.